FIELD: medicine, pharmacy. SUBSTANCE: invention relates to derivatives of melatonin used for treatment of sleep disorders. Indicated compounds can be components of compositions in combination with acceptable carriers. EFFECT: enhanced effectiveness, absence of adverse effects as compared with known agents. 10 cl, 8 ex
Authors
Dates
2000-03-10—Published
1994-11-16—Filed